Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2

1(50.0%)

N/A

1(50.0%)

2Total

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06515821Recruiting

Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods

Role: lead

NCT05160337Not ApplicableRecruiting

Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers

Role: lead

NCT07058688Phase 2Recruiting

A Study of NTRX-07 in Participants With Alzheimer's Disease

Role: collaborator

NCT06432192Completed

A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis

Role: lead

NCT03030586Completed

ADDIA Proof-of-Performance Clinical Study

Role: collaborator

NCT03322436Completed

HeartLinc, a Study With AMI Patients Undergoing PCI

Role: lead

NCT04583319Completed

Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection

Role: lead

NCT04189029Active Not Recruiting

PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study

Role: collaborator

NCT03038360Completed

Prospective Study With AMI Patients Undergoing PCI

Role: lead

All 9 trials loaded